4-PLEX RESPIRATORY PATHOGEN RT-PCR (FDA)

FDA-APPROVED

4-PLEX RESPIRATORY PATHOGEN RT-PCR

Overview

Acute respiratory infections represent a major global health burden, particularly during seasonal outbreaks and pandemics. The COVID-19,Influenza A/B, and RSV Multiplex PCR Panel offered by PreCheck Health Services provides rapid, accurate, and comprehensive molecular detection of the most prevalent respiratory viruses in a single test. This panel enhances diagnostic accuracy, supports effective isolation and treatment decisions, and reduces unnecessary use of antibiotics.

Who Benefits from Respiratory Pathogen Panel Testing?

This panel is recommended for:
- Patients with acute respiratory symptoms (e.g., cough, fever, shortness of breath)
- Hospitalized individuals with pneumonia or lower respiratory tract infection
- Pediatric and geriatric patients at high risk for respiratory complications
- Immunocompromised individuals
- Healthcare workers or caregivers with known or suspected exposures
- Situations requiring rapid differentiation between COVID-19, Influenza, and RSV for targeted therapy and infection control

Pathogens Covered and Functional Utility

The panel simultaneously detects and differentiates the following respiratory viruses:

✅ Respiratory Syncytial Virus (RSV)
✅ Influenza A
✅ Influenza B
✅ COVID-19 (SARS-CoV-2)

This test aids in:
✅ Diagnosing co-infections
✅ Guiding treatment decisions (antivirals, isolation protocols)
✅ Reducing unnecessary antibiotic prescriptions
✅ Supporting public health tracking and outbreak response

Technical Specifications

Panel Type - Multiplex  Real-Time Reverse Transcription PCR (RT-PCR)

Sample Type - Nasopharyngeal Swabs

Pathogens Detected - SARS-CoV-2,  Influenza A, Influenza B, RSV

Turnaround Time - 24 hours  from sample receipt

Shipping Conditions - Cold chain  (ice packs); ship within 24 hours

Regulatory Status - Developed  under validated laboratory protocols (CLIA ID: 10D2210020)

Test Methodology

This multiplex respiratory panel employs real-time reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA. Patient specimens are collected via swab (nasopharyngeal, nasal, or oropharyngeal), followed by RNA extraction and amplification using pathogen-specific primers and probes.

The assay is optimized for sensitivity and specificity in clinical respiratory samples. Internal and external controls are included in each run. Results are interpreted by certified molecular professionals using validated analysis software.

Conclusion

Multiplex PCR Panel from PreCheck Health Services provides a rapid, reliable, and clinically relevant diagnostic tool to guide treatment, limit viral spread, and improve outcomes in patients with respiratory symptoms.This panel is critical in both community and institutional settings to ensure timely and appropriate care.

For inquiries or to learn more about our testing solutions, please contact us.‍